{"url_path":"/sec/alzn/10-k/2026/item-12","section_key":"item-12","section_title":"Item 12 ****SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1677077/0001214659-26-008832-index.html","accession_number":"0001214659-26-008832","cik":"0001677077","ticker":"ALZN","issuer_name":"Alzamend Neuro, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1677077/0001214659-26-008832-index.html","primary_entity_key":"0001677077","primary_entity_name":"Alzamend Neuro, Inc."},"word_count":777,"has_tables":true,"body_markdown":"**ITEM 12.****SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS**\n\n \n\nThe following table shows the beneficial ownership of our common stock\nas of July 22, 2026, held by (i) each person known by us to be the beneficial owner of more than 5% of our outstanding common stock,\n(ii) each of our directors and director nominees, (iii) each of our executive officers, and (iv) all of our directors,\ndirector nominees and executive officers as a group. As of July 22, 2026, there were 4,791,525 shares of our common stock issued and outstanding.\n\n \n\nBeneficial ownership is determined\nin accordance with the rules of the SEC, and generally includes voting power and/or investment power with respect to the securities held.\nShares of our common stock subject to options and warrants currently exercisable or which may become exercisable within 60 days of\nthe date of this Annual Report, are deemed outstanding and beneficially owned by the person holding such options or warrants for purposes\nof computing the number of shares and percentage beneficially owned by such person but are not deemed outstanding for purposes of\ncomputing the percentage beneficially owned by any other person. Except as indicated in the footnotes to this table, the persons\nor entities named have sole voting and investment power with respect to all shares of our common stock shown as beneficially owned by\nthem.\n\n \n\nUnless otherwise noted in\nthe footnotes to the following table, and subject to applicable community property laws, the persons named in the table have sole voting\nand investment power with respect to their beneficially owned common stock.\n\n \n\nUnless otherwise indicated,\nthe principal address of each of the persons below is c/o Alzamend Neuro, Inc., 3480 Peachtree Road NE, Second Floor, Suite 103,\nAtlanta, GA 30326.\n\n \n\nDirectors and Executive Officers: \nNumber of shares of\nCommon Stock\nBeneficially Owned  \nPercentage of Shares\nBeneficially\nOwned \n\nMilton C. Ault, III **(1)** \n 213,010  \n 4.37%\n\nStephan Jackman **(2)** \n 271,925  \n 5.37%\n\nDavid J. Katzoff **(3)** \n 182,976  \n 3.68%\n\nHenry C.W. Nisser **(4)** \n 36,250  \n * \n\nWilliam B. Horne **(5)** \n 36,250  \n * \n\nMark Gustafson **(6)** \n 36,294  \n * \n\nJeffrey Oram **(7)** \n 36,324  \n * \n\nAll directors and named executive officers as a group (7 persons) \n 813,029  \n 14.65%\n\n  \n\n*\nLess than 1% of outstanding shares.​\n\n \n\n(1)Consists of (i) 116,648 shares of common stock held by Ault Lending, (ii) 11,068 shares of common stock\nheld by ALSI, (iii) 61 shares of common stock held by ALSF, (iv) 24,816 shares of common stock issuable upon exercise of currently exercisable\nwarrants held by Ault Lending, and (v) 60,417 shares of our common stock issuable upon the exercise of stock options that are currently\nexercisable or exercisable within 60 days.  Ault Lending is a wholly-owned subsidiary of Hyperscale Data. Mr. Ault, the Executive\nChairman of Hyperscale Data, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.\nMr. Ault has sole voting and investment power with respect to the securities held of record by ALSI and ALSF.\n\n \n\n(2)Consist of (i) 50 shares of our common stock and (ii) 271,875 shares of our common stock issuable upon\nthe exercise of stock options that are currently exercisable or exercisable within 60 days.\n\n \n\n - 63 - \n\n \n\n \n\n(3)Consists of (i) 615 shares of our common stock and (ii) 182,361 shares of our common stock issuable upon\nthe exercise of stock options that are currently exercisable or exercisable within 60 days.\n\n \n\n(4)Represents shares of our common stock issuable upon the exercise of stock options, which are currently\nexercisable or exercisable within 60 days. Mr. Nisser’s address is 122 East 42nd Street, 50th Floor, Suite 5000, New York, New York\n10168.\n\n  \n\n(5)Represents shares of our common stock issuable upon the exercise of stock options, which are currently\nexercisable or exercisable within 60 days.\n\n \n\n(6)Consists of (i) 44 shares of our common stock and (ii) 36,250 shares of our common stock issuable upon\nthe exercise of stock options that are currently exercisable or exercisable within 60 days.\n\n \n\n(7)Consists of (i) 74 shares of our common stock and (ii) 36,250 shares of our common stock issuable upon\nthe exercise of stock options that are currently exercisable or exercisable within 60 days.\n\n \n\n**Equity Compensation Information**\n\n \n\nThe following table summarizes information about\nour equity compensation plans as of April 30, 2026:\n\n \n\n  \n   \n   \nNumber of securities\n\n  \nNumber of securities  \nWeighted-  \nremaining available for\n\n  \nto be issued  \naverage  \nfuture issuance under\n\n  \nupon exercise  \nexercise price  \nequity compensation plans\n\n  \nof outstanding  \nof outstanding  \n(excluding securities\n\n  \noptions, warrants and rights  \noptions, warrants and rights  \nreflected in column (a))\n\nPlan Category \n(a)  \n(b)  \n(c)\n\nEquity compensation plans approved by stockholders \n 1,593,704  \n$6.32  \n10,000\n\nEquity compensation plans not approved by stockholders \n 3,296  \n 2,080.77  \n-\n\nTotal \n 1,597,000  \n$10.60  \n10,000"}